Morphine Sulfate
- Product NDC
- 63629-4483
- 11-digit product format
- 636294483
- Labeler code
- 63629
- Product ID
- 63629-4483_a6e982b8-e597-4955-9387-b1404883682b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Morphine Sulfate
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA074862
- Marketing category
- ANDA
- Marketing start
- 2011-01-14
- Substance
- MORPHINE SULFATE
- Active strength
- 15 mg/1
- Pharmacologic classes
- Full Opioid Agonists [MoA], Opioid Agonist [EPC]
- DEA schedule
- CII
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Morphine Sulfate
- Brand name suffix
- ER
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| MORPHINE SULFATE | 15 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | X3P646A2J0 |
| Rxcui | 891881 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 63629-4483-0 | 2022-01-03 | C162847 | 48780-1 | 9d75b9d0-25f0-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use morphine sulfate extended-release tablets safely and effectively. See full prescribing information for morphine sulfate extended-release tablets. MORPHINE sulfate extended-release tablets for oral use, CII Initial U.S. Approval: 1941 |
| 63629-4483-1 | 2022-01-03 | C162847 | 48780-1 | 9d75b9d0-25f0-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use morphine sulfate extended-release tablets safely and effectively. See full prescribing information for morphine sulfate extended-release tablets. MORPHINE sulfate extended-release tablets for oral use, CII Initial U.S. Approval: 1941 |
| 63629-4483-2 | 2022-01-03 | C162847 | 48780-1 | 9d75b9d0-25f0-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use morphine sulfate extended-release tablets safely and effectively. See full prescribing information for morphine sulfate extended-release tablets. MORPHINE sulfate extended-release tablets for oral use, CII Initial U.S. Approval: 1941 |
| 63629-4483-3 | 2022-01-03 | C162847 | 48780-1 | 9d75b9d0-25f0-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use morphine sulfate extended-release tablets safely and effectively. See full prescribing information for morphine sulfate extended-release tablets. MORPHINE sulfate extended-release tablets for oral use, CII Initial U.S. Approval: 1941 |
| 63629-4483-4 | 2022-01-03 | C162847 | 48780-1 | 9d75b9d0-25f0-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use morphine sulfate extended-release tablets safely and effectively. See full prescribing information for morphine sulfate extended-release tablets. MORPHINE sulfate extended-release tablets for oral use, CII Initial U.S. Approval: 1941 |
| 63629-4483-5 | 2022-01-03 | C162847 | 48780-1 | 9d75b9d0-25f0-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use morphine sulfate extended-release tablets safely and effectively. See full prescribing information for morphine sulfate extended-release tablets. MORPHINE sulfate extended-release tablets for oral use, CII Initial U.S. Approval: 1941 |
| 63629-4483-6 | 2022-01-03 | C162847 | 48780-1 | 9d75b9d0-25f0-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use morphine sulfate extended-release tablets safely and effectively. See full prescribing information for morphine sulfate extended-release tablets. MORPHINE sulfate extended-release tablets for oral use, CII Initial U.S. Approval: 1941 |
| 63629-4483-7 | 2022-01-03 | C162847 | 48780-1 | 9d75b9d0-25f0-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use morphine sulfate extended-release tablets safely and effectively. See full prescribing information for morphine sulfate extended-release tablets. MORPHINE sulfate extended-release tablets for oral use, CII Initial U.S. Approval: 1941 |
| 63629-4483-8 | 2022-01-03 | C162847 | 48780-1 | 9d75b9d0-25f0-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use morphine sulfate extended-release tablets safely and effectively. See full prescribing information for morphine sulfate extended-release tablets. MORPHINE sulfate extended-release tablets for oral use, CII Initial U.S. Approval: 1941 |
| 63629-4483-9 | 2022-01-03 | C162847 | 48780-1 | 9d75b9d0-25f0-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use morphine sulfate extended-release tablets safely and effectively. See full prescribing information for morphine sulfate extended-release tablets. MORPHINE sulfate extended-release tablets for oral use, CII Initial U.S. Approval: 1941 |
| 63629-4483-0 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-25f0-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use morphine sulfate extended-release tablets safely and effectively. See full prescribing information for morphine sulfate extended-release tablets. MORPHINE sulfate extended-release tablets for oral use, CII Initial U.S. Approval: 1941 |
| 63629-4483-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-25f0-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use morphine sulfate extended-release tablets safely and effectively. See full prescribing information for morphine sulfate extended-release tablets. MORPHINE sulfate extended-release tablets for oral use, CII Initial U.S. Approval: 1941 |
| 63629-4483-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-25f0-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use morphine sulfate extended-release tablets safely and effectively. See full prescribing information for morphine sulfate extended-release tablets. MORPHINE sulfate extended-release tablets for oral use, CII Initial U.S. Approval: 1941 |
| 63629-4483-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-25f0-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use morphine sulfate extended-release tablets safely and effectively. See full prescribing information for morphine sulfate extended-release tablets. MORPHINE sulfate extended-release tablets for oral use, CII Initial U.S. Approval: 1941 |
| 63629-4483-4 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-25f0-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use morphine sulfate extended-release tablets safely and effectively. See full prescribing information for morphine sulfate extended-release tablets. MORPHINE sulfate extended-release tablets for oral use, CII Initial U.S. Approval: 1941 |
| 63629-4483-5 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-25f0-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use morphine sulfate extended-release tablets safely and effectively. See full prescribing information for morphine sulfate extended-release tablets. MORPHINE sulfate extended-release tablets for oral use, CII Initial U.S. Approval: 1941 |
| 63629-4483-6 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-25f0-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use morphine sulfate extended-release tablets safely and effectively. See full prescribing information for morphine sulfate extended-release tablets. MORPHINE sulfate extended-release tablets for oral use, CII Initial U.S. Approval: 1941 |
| 63629-4483-7 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-25f0-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use morphine sulfate extended-release tablets safely and effectively. See full prescribing information for morphine sulfate extended-release tablets. MORPHINE sulfate extended-release tablets for oral use, CII Initial U.S. Approval: 1941 |
| 63629-4483-8 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-25f0-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use morphine sulfate extended-release tablets safely and effectively. See full prescribing information for morphine sulfate extended-release tablets. MORPHINE sulfate extended-release tablets for oral use, CII Initial U.S. Approval: 1941 |
| 63629-4483-9 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-25f0-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use morphine sulfate extended-release tablets safely and effectively. See full prescribing information for morphine sulfate extended-release tablets. MORPHINE sulfate extended-release tablets for oral use, CII Initial U.S. Approval: 1941 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 63629-4483-0 | Morphine SulfateER | 26 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 26 | | 1017 |
| 63629-4483-1 | Morphine SulfateER | 30 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 30 | | 1017 |
| 63629-4483-2 | Morphine SulfateER | 60 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 60 | | 1017 |
| 63629-4483-3 | Morphine SulfateER | 90 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 90 | | 1017 |
| 63629-4483-4 | Morphine SulfateER | 120 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 120 | | 1017 |
| 63629-4483-5 | Morphine SulfateER | 40 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 40 | | 1017 |
| 63629-4483-6 | Morphine SulfateER | 14 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 14 | | 1017 |
| 63629-4483-7 | Morphine SulfateER | 15 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 15 | | 1017 |
| 63629-4483-8 | Morphine SulfateER | 20 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 20 | | 1017 |
| 63629-4483-9 | Morphine SulfateER | 84 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 84 | | 1017 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 4 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 4 | |
| CETOSTEARYL ALCOHOL | INACTIVE INGREDIENT | 2DMT128M1S | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 4 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 4 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | INACTIVE INGREDIENT | 8136Y38GY5 | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 4 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 4 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 4 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 4 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 4 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 4 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 4 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | MORPHINE SULFATE TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 4 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 63629-4483 | MORPHINE SULFATE ER (MORPHINE SULFATE) TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1016 | Current NDC, Legacy NDC, 10 package rows | 20240524_872ceecb-1f14-7a43-7451-e4650a01fbd9.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63629-4483-0 | 63629448300 | 26 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4483-0) | 2022-01-03 | 0000-00-00 | No | No | Current |
| 63629-4483-1 | 63629448301 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4483-1) | 2011-04-20 | 0000-00-00 | No | No | Current |
| 63629-4483-2 | 63629448302 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4483-2) | 2011-04-14 | 0000-00-00 | No | No | Current |
| 63629-4483-3 | 63629448303 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4483-3) | 2011-07-11 | 0000-00-00 | No | No | Current |
| 63629-4483-4 | 63629448304 | 120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4483-4) | 2022-01-03 | 0000-00-00 | No | No | Current |
| 63629-4483-5 | 63629448305 | 40 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4483-5) | 2022-01-03 | 0000-00-00 | No | No | Current |
| 63629-4483-6 | 63629448306 | 14 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4483-6) | 2012-08-13 | 0000-00-00 | No | No | Current |
| 63629-4483-7 | 63629448307 | 15 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4483-7) | 2014-04-29 | 0000-00-00 | No | No | Current |
| 63629-4483-8 | 63629448308 | 20 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4483-8) | 2022-01-03 | 0000-00-00 | No | No | Current |
| 63629-4483-9 | 63629448309 | 84 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4483-9) | 2015-04-15 | 0000-00-00 | No | No | Current |